Tens of thousands of bottles of cholesterol medication have been recalled across the country.

Zydus Pharmaceuticals (USA) Inc. and AvKARE have recalled their respective drugs due to manufacturing and quality issues that could affect the drug’s potency, according to two separate statements from the Food and Drug Administration (FDA).

Zydus Pharmaceuticals is recalling approximately 22,896 bottles of Icosapent Ethyl capsules. The drug, manufactured by Softgel Healthcare and distributed in 120-count bottles, was classified as a subpotency drug.

FDA PICKS UP ‘RED TAPE’ IN MOVE ALIGNED WITH TRUMP PUSH TO SPEED NEW TREATMENTS

Oxidation caused by the leaking capsules reduced the drug’s strength, federal officials warned. In turn, use of the medication “may result in inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients,” the recall notice says.

Tens of thousands of bottles of cholesterol medication have been recalled across the country. (Getty Images)

The FDA classified the recall as Class II, meaning the products involved in the recall “may cause temporary and medically reversible health problems.” Serious consequences are also considered “remote”.

FDA RECALLS JOINT PRESSURE DRUGS FOR CHOLESTEROL CONTAMINATION

AvKARE also recalled thousands of bottles of rosuvastatin tablets, packaged in unit-dose cartons of 50 tablets, according to a separate notice.

Zydus Pharmaceuticals (USA) Inc. and AvKARE have recalled their respective drugs due to manufacturing and quality issues. (Getty Images)

The drug, according to federal officials, does not dissolve as it should once you take it.

The FDA also classified this recall as Class II.

Both monuments are classified as Class II. (George Frey/Bloomberg via Getty Images)

GET THE FOX BUSINESS ANYWHERE CLICK HERE

Both memories are still considered ongoing.